Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Wang-Chun Chen"'
Autor:
Yu Chang Chen, Wang-Chun Chen, Chia-Wei Liu, Wei-Yu Huang, ICheng Lu, Chi Wei Lin, Ru Yi Huang, Jung Sheng Chen, Chi Hsien Huang
Publikováno v:
European Review of Aging and Physical Activity, Vol 20, Iss 1, Pp 1-22 (2023)
Abstract Background Resistance training (RT) and nutritional supplementation are recommended for the management of sarcopenia in older adults. However, optimal RT intensity for the treatment of sarcopenia has not been well investigated. Methods This
Externí odkaz:
https://doaj.org/article/cce0294341aa4dc4b8ae3290ba3f882d
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 8, Pp 896-901 (2022)
Objectives: This meta-analysis of randomized controlled trials (RCTs) investigated the usefulness of mesenchymal stromal cells (MSCs) to treat patients with COVID-19. Methods: PubMed, Embase, Ovid MEDLINE, the Cochrane Library, and Clinicaltrials.gov
Externí odkaz:
https://doaj.org/article/0f3d5e866b9242c4bab61dbe63af506e
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundIt is unknown whether clinically indicated replacement of peripheral intravenous catheters (PIVCs) increases the risks of PIVC-associated complications and infections compared to routine replacement of PIVCs.MethodsWe searched PubMed, the W
Externí odkaz:
https://doaj.org/article/dc66680392844f6c93446d62dd32b00e
Autor:
Ching-Yi Chen, Wang-Chun Chen, Chi-Hsien Huang, Yi-Ping Hsiang, Chau-Chyun Sheu, Yung-Che Chen, Meng-Chih Lin, Kuo-An Chu, Cheng-Hung Lee, Yu-Feng Wei
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: Long-acting muscarinic antagonist (LAMA) monotherapy is recommended for chronic obstructive pulmonary disease (COPD) patients with high risk of exacerbations. It is unclear whether long-acting β2-agonist (LABA)/LAMA fixed-dose combinatio
Externí odkaz:
https://doaj.org/article/5f49346c471a43f5b6b32c47a743e583
Publikováno v:
Antibiotics, Vol 10, Iss 8, p 1020 (2021)
This systematic review and meta-analysis of randomized controlled trials (RCTs) compared the clinical efficacy and safety of anti-MRSA cephalosporin and vancomycin-based treatment in treating acute bacterial skin and skin structure infections (ABSSSI
Externí odkaz:
https://doaj.org/article/f23e3d70912843b6b6a9ab1558ddf669
Autor:
Wang-Chun Chen, 陳宛君
100
Objective Microsurgical free flap are today standard of care for head and neck reconstruction after tumor resections. Nearly 96% doctors would prescribe systemic medication for increasing the survival of the flap to maintain the permeability
Objective Microsurgical free flap are today standard of care for head and neck reconstruction after tumor resections. Nearly 96% doctors would prescribe systemic medication for increasing the survival of the flap to maintain the permeability
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/80392085233061245495
Publikováno v:
Expert review of anti-infective therapy. 20(10)
Severe-to-critical COVID-19 has been associated with exaggerated immune responses, and anti-inflammatory agents including corticosteroid and interleukin-6 antagonist have been repurposed as the treatment modality against severe SARS-CoV-2 infections.
Backgrounds: Immune checkpoint inhibitors (ICIs) alone or in combination with chemotherapy (CT) are the standard of care for first-line therapy in metastatic non-small cell lung cancer (NSCLC) patients without actionable mutations. The safety ranking
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30adaf922e60371bef52260ba29dc7d6
https://doi.org/10.21203/rs.3.rs-1168265/v1
https://doi.org/10.21203/rs.3.rs-1168265/v1
Publikováno v:
Expert review of anti-infective therapy. 20(3)
This systematic review and meta-analysis aimed to investigate the clinical efficacy and safety of novel lipoglycopeptides in treating acute bacterial skin and skin structure infections (ABSSSIs). PubMed, Embase, Cochrane Central Register of Controlle
Publikováno v:
International Journal of Antimicrobial Agents
Objective This systematic review and meta-analysis examined the efficacy of sofosbuvir-based antiviral agents against coronavirus disease 2019 (COVID-19). Methods PubMed, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov